Literature DB >> 31028655

Correlation of constitutive photomorphogenic 1 (COP1) and p27 tumor suppressor protein expression in ovarian cancer.

Eun-Ji Ko1,2, Young Lim Oh3, Heung Yeol Kim3, Wan Kyu Eo4, Hongbae Kim5, Ki Hyung Kim6,7, Suk Bong Koh8, Mee Sun Ock1, Yung Hyun Choi9, Ari Kim10, Hyun Ho Choi11,12, Eun Joo Park13, Hee-Jae Cha14.   

Abstract

BACKGROUND: Constitutive photomorphogenic 1 (COP1) is an E3 ubiquitin ligase that regulates important target proteins for cell growth including p27. The tumor suppressor p27 negatively regulates the cell cycle by inhibiting cyclin-dependent kinase. COP1 negatively regulates p27 stability by mediating its nuclear export and degradation.
OBJECTIVE: Even if COP1 and p27 are tightly related and have significant roles in tumor progression, the expression patterns and relationship of both proteins in cancer have not yet been studied.
METHOD: We analyzed the expression patterns and relationship between COP1 and p27 using an ovarian cancer tissue microarray by dual immunofluorescence analysis.
RESULTS: The expression levels of COP1 and p27 proteins were not significantly different between ovarian cancer tissue and normal control tissue. Other clinical data including age, tumor type, tumor grade, and stage were not significantly related to expression of the two proteins. The co-relationship between COP1 and p27 proteins was significantly high (Pearson correlation coefficient 0.79, p = 8.65 × 10-22).
CONCLUSIONS: Our results demonstrate that while the expression levels of COP1 and p27 are highly correlated, they are not significantly related to cancer progression in ovarian cancer.

Entities:  

Keywords:  COP1; Expression; Ovarian cancer; Tissue microarray; p27

Mesh:

Substances:

Year:  2019        PMID: 31028655     DOI: 10.1007/s13258-019-00818-6

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  30 in total

1.  p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis.

Authors:  H Y Yang; R Shao; M C Hung; M H Lee
Journal:  Oncogene       Date:  2001-06-21       Impact factor: 9.867

2.  Loss of COP1 expression determines poor prognosisin patients with gastric cancer.

Authors:  Genta Sawada; Hiroki Ueo; Tae Matsumura; Ryutaro Uchi; Masahisa Ishibashi; Kosuke Mima; Junji Kurashige; Yusuke Takahashi; Sayuri Akiyoshi; Tomoya Sudo; Keishi Sugimachi; Yuichiro Doki; Masaki Mori; Koshi Mimori
Journal:  Oncol Rep       Date:  2013-08-08       Impact factor: 3.906

3.  Correlation of p27 protein expression with HER-2/neu expression in breast cancer.

Authors:  L Newman; W Xia; H Y Yang; A Sahin; M Bondy; F Lukmanji; M C Hung; M H Lee
Journal:  Mol Carcinog       Date:  2001-03       Impact factor: 4.784

4.  TRIB2 inhibits Wnt/β-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β-TrCP, COP1 and Smurf1, in liver cancer cells.

Authors:  Shanshan Xu; Minghong Tong; Jingqin Huang; Yue Zhang; Yongxia Qiao; Wenhao Weng; Weiwei Liu; Jiayi Wang; Fenyong Sun
Journal:  FEBS Lett       Date:  2014-10-13       Impact factor: 4.124

5.  The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.

Authors:  Won Hye Ka; Seok Keun Cho; Byung Nyun Chun; Sang Yo Byun; Jong Cheol Ahn
Journal:  Breast Cancer       Date:  2018-03-07       Impact factor: 4.239

6.  Cyclin D1 predicts the prognosis of advanced serous ovarian cancer.

Authors:  Tomoko Hashimoto; Nozomu Yanaihara; Aikou Okamoto; Takashi Nikaido; Misato Saito; Satoshi Takakura; Makoto Yasuda; Hiroshi Sasaki; Kazunori Ochiai; Tadao Tanaka
Journal:  Exp Ther Med       Date:  2011-01-18       Impact factor: 2.447

7.  Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity.

Authors:  Huiling Yang; Ruiying Zhao; Heng-Yin Yang; Mong-Hong Lee
Journal:  Oncogene       Date:  2005-03-10       Impact factor: 9.867

8.  COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.

Authors:  David Dornan; Sheila Bheddah; Kim Newton; William Ince; Gretchen D Frantz; Patrick Dowd; Hartmut Koeppen; Vishva M Dixit; Dorothy M French
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

9.  Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.

Authors:  Anish Bali; Philippa M O'Brien; Lyndal S Edwards; Robert L Sutherland; Neville F Hacker; Susan M Henshall
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

10.  Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy.

Authors:  Hui Zhao; Claire M Faltermeier; Lori Mendelsohn; Peggy L Porter; Bruce E Clurman; James M Roberts
Journal:  Oncotarget       Date:  2014-12-30
View more
  2 in total

1.  Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma.

Authors:  Mengjie Guo; Pinggang Ding; Zhen Zhu; Lu Fan; Yanyan Zhou; Shu Yang; Ye Yang; Chunyan Gu
Journal:  Front Cell Dev Biol       Date:  2021-04-21

Review 2.  Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins.

Authors:  Sang-Soo Park; Kwang-Hyun Baek
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.